NO20002099D0 - 6,11-bro-erytromycinderivater - Google Patents

6,11-bro-erytromycinderivater

Info

Publication number
NO20002099D0
NO20002099D0 NO20002099A NO20002099A NO20002099D0 NO 20002099 D0 NO20002099 D0 NO 20002099D0 NO 20002099 A NO20002099 A NO 20002099A NO 20002099 A NO20002099 A NO 20002099A NO 20002099 D0 NO20002099 D0 NO 20002099D0
Authority
NO
Norway
Prior art keywords
erythromycin derivative
bridged erythromycin
bridged
derivative
erythromycin
Prior art date
Application number
NO20002099A
Other languages
English (en)
Other versions
NO20002099L (no
Inventor
Yat Sun Or
George W Griesgraber
Leping Li
Daniel T Chu
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20002099D0 publication Critical patent/NO20002099D0/no
Publication of NO20002099L publication Critical patent/NO20002099L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20002099A 1997-10-29 2000-04-25 6,11-bro-erytromycinderivater NO20002099L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96040097A 1997-10-29 1997-10-29
US15826998A 1998-09-22 1998-09-22
PCT/US1998/022941 WO1999021864A1 (en) 1997-10-29 1998-10-29 6,11-bridged erythromycin derivatives

Publications (2)

Publication Number Publication Date
NO20002099D0 true NO20002099D0 (no) 2000-04-25
NO20002099L NO20002099L (no) 2000-06-29

Family

ID=26854886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002099A NO20002099L (no) 1997-10-29 2000-04-25 6,11-bro-erytromycinderivater

Country Status (23)

Country Link
EP (1) EP1027361B1 (no)
JP (1) JP2001521038A (no)
KR (1) KR20010031591A (no)
CN (1) CN1278266A (no)
AR (1) AR015986A1 (no)
AT (1) ATE239750T1 (no)
AU (1) AU1286799A (no)
BG (1) BG104425A (no)
BR (1) BR9813317A (no)
CA (1) CA2307828A1 (no)
CO (1) CO4990972A1 (no)
DE (1) DE69814441T2 (no)
DK (1) DK1027361T3 (no)
ES (1) ES2198766T3 (no)
HU (1) HUP0004323A2 (no)
IL (1) IL134996A0 (no)
NO (1) NO20002099L (no)
PL (1) PL340253A1 (no)
PT (1) PT1027361E (no)
SK (1) SK6342000A3 (no)
TR (1) TR200001140T2 (no)
TW (1) TW486485B (no)
WO (1) WO1999021864A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6437106B1 (en) * 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
CN1589277A (zh) 2001-09-17 2005-03-02 奥索-麦克尼尔药品公司 6－o－氨基甲酸酯－11,12－内酯－酮内酯抗菌剂
CA2469304A1 (en) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. 6-o acyl ketolide antibacterials
US7910558B2 (en) * 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7273853B2 (en) 2002-05-13 2007-09-25 Enanta Pharmaceuticals, Inc. 6-11 bicyclic ketolide derivatives
US6753318B1 (en) 2002-07-25 2004-06-22 Enanta Pharmaceuticals, Inc. 6,11-4-carbon bridged erythromycin derivatives
CN1659178A (zh) 2002-05-13 2005-08-24 英安塔制药有限公司 6、11二环红霉素衍生物
US6841664B2 (en) 2002-07-25 2005-01-11 Enanra Pharmaceuticals, Inc. 6,11-4-carbon bridged ketolides
WO2003095466A1 (en) * 2002-05-13 2003-11-20 Enanta Pharmaceuticals, Inc. 6,11 bicyclic erythromycin derivatives
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7414030B2 (en) 2004-01-07 2008-08-19 Enanta Pharmaceuticals, Inc. 6-11 Bicyclic erythromycin derivatives
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
WO2005080408A1 (en) * 2004-01-23 2005-09-01 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7384921B2 (en) 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
US7384922B2 (en) 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US7589067B2 (en) 2005-10-12 2009-09-15 Enanta Pharmaceuticals, Inc. 6, 11-bridged tricyclic macrolides
US8273720B2 (en) 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
WO2018201076A2 (en) * 2017-04-28 2018-11-01 Macrolide Pharmaceuticals Inc. Macrolides with modified desosamine sugars and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997017356A1 (en) * 1995-11-08 1997-05-15 Abbott Laboratories Tricyclic erythromycin derivatives

Also Published As

Publication number Publication date
CA2307828A1 (en) 1999-05-06
SK6342000A3 (en) 2000-09-12
DE69814441T2 (de) 2004-04-08
DK1027361T3 (da) 2003-08-25
EP1027361A1 (en) 2000-08-16
BG104425A (bg) 2001-01-31
TR200001140T2 (tr) 2001-05-21
HUP0004323A2 (hu) 2001-02-28
AU1286799A (en) 1999-05-17
CN1278266A (zh) 2000-12-27
CO4990972A1 (es) 2000-12-26
KR20010031591A (ko) 2001-04-16
BR9813317A (pt) 2000-08-22
AR015986A1 (es) 2001-05-30
DE69814441D1 (de) 2003-06-12
IL134996A0 (en) 2001-05-20
PT1027361E (pt) 2003-09-30
ATE239750T1 (de) 2003-05-15
TW486485B (en) 2002-05-11
WO1999021864A1 (en) 1999-05-06
PL340253A1 (en) 2001-01-29
JP2001521038A (ja) 2001-11-06
ES2198766T3 (es) 2004-02-01
NO20002099L (no) 2000-06-29
EP1027361B1 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt) 4,5-diaril-imidazoles 2-substituidos
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
DE69736711D1 (de) Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da) Substituerede 6,6-heterobicykliske derivater
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
ATE275151T1 (de) 3,6-ketal-makrolidantibiotika
DE69718771T2 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
NO20002099D0 (no) 6,11-bro-erytromycinderivater
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
EE04089B1 (et) 1,3,4-oksadiasolooni derivaadid
LV11898A (lv) Eritromicina atvasinajumi
DK1149106T3 (da) 4,5-azolo-oxindoler
DK1068200T3 (da) 2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ID26368A (id) Turunan-turunan 2 deoksi higromisin
DE69722064D1 (de) 1,25-Dihydroxy-16,22,23-trisdehydro-Cholecalciferol-Derivate
PT984975E (pt) Derivados de eritromicina multiciclicos
BR1100453A (pt) derivados de eritromicina
ZA989848B (en) 6,11-bridged erythromycin derivatives
SI1015467T1 (en) 6,9-bridged erythromycin derivatives
SI1027361T1 (en) 6,11-bridged erythromycin derivatives
BR1100649A (pt) Derivados de 10,11-metano dibenzo suberano

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application